Recalls
Breckenridge recalls one lot of propranolol over potential metal contamination
Consumers should stop taking the affected lot and contact a health care provider for advice and replacement instructions.

Breckenridge Pharmaceutical is voluntarily recalling one lot of Propranolol Hydrochloride Extended-Release Capsules, USP, 60 mg, because of potential metal contamination. The FDA posted the company’s announcement on November 16, 2026. Breckenridge said use of the affected product could cause lacerations in the mouth, esophagus, stomach or intestine. The company said the lot shared intermediate material suspected to be the source of metal contamination found in a separate lot that was not released to market. Breckenridge said it was not aware of adverse events assessed to be related to the recall.
The affected product was distributed nationwide to wholesalers and pharmacies between October 26, 2026 and November 04, 2026. Consumers should stop taking product from the affected lot, contact a physician or health care provider for advice and replacement instructions, and return unused product to the pharmacy where it was obtained. Wholesalers, pharmacies and other retail entities should quarantine affected product and not distribute or dispense it.


